Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX-P4-003 Microdose PK Study in Healthy Volunteers
NCT04638803Phase 1Completed
- Sponsor
- Praxis Bioresearch
- Start
- Feb 2021
- Primary completion
- Oct 2021
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of PRX-P4-003 in apathy (3 arms), sponsored by Praxis Bioresearch. Primary endpoint: Area Under the Curve from Time Zero to Last Quantifiable Concentration at 24 hours. Started Feb 2021; status: completed.
02
Drugs
PRX-P4-003
03
Conditions
apathy
Beyond the preview
Go deeper on NCT04638803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04638803.